StockData
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

LEMAITRE VASCULAR INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$82.31+1.49 (+1.84%)

Close on Oct 19, 2026

Market cap
$2.02B
P/E (TTM)
28.9
Dividend yield
0.97%

Earnings

Next report expected Nov 5, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 4, 2026After market close$70.40M$0.74–
Q1 FY2026
Ended Mar 31, 2026
May 5, 2026After market close$66.60M$0.68–
Q4 FY2025
Ended Dec 31, 2025
Feb 25, 2026After market close$64.50M$0.68–
Q3 FY2025
Ended Sep 30, 2025
Nov 6, 2025After market close$61.00M$0.75$0.62
Q2 FY2025
Ended Jun 30, 2025
Aug 5, 2025After market close$64.20M$0.60–
Q1 FY2025
Ended Mar 31, 2025
May 1, 2025After market close$59.87M$0.48–
Q4 FY2024
Ended Dec 31, 2024
Feb 27, 2025After market close$55.70M$0.49$0.49
Q3 FY2024
Ended Sep 30, 2024
Oct 31, 2024After market close$54.80M$0.49–
Q2 FY2024
Ended Jun 30, 2024
Aug 1, 2024After market close–––
Q1 FY2024
Ended Mar 31, 2024
May 2, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Feb 27, 2024After market close–––

Company guidance

Outlook given with results on Aug 4, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
EPSFull Year$2.84 to $2.94Lowered
EPSQ4 2026$0.75 to $0.81New
EPSQ3 2026$0.66 to $0.71New
Op. IncomeQ4 2026$19.80M to $21.20MNew
Op. IncomeFull Year$75.30M to $78.20MLowered
Op. IncomeQ3 2026$17.30M to $18.80MNew
SalesFull Year$274.30M to $278.30MLowered
SalesQ4 2026$71.10M to $73.10MNew
SalesQ3 2026$66.30M to $68.30MNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Lemaitre Vascular filed with the SEC